BARDA

BARDA

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

BARDA Moves Forward on Freeze-Dried Smallpox Vaccine

BARDA Awards Medical Countermeasure Clinical Studies Network Contracts

Year-Round Access to Embryonated Eggs for Pandemic Flu Vaccine

Bavarian Nordic to Develop Biodefense Vaccine

BARDA Funds Countermeasure for Burkholderia Infections

PharmAthene Calls Off Merger Agreement with Theraclone

Bavarian Nordic Completes Smallpox Vaccine Delivery to SNS

New PharmAthene Anthrax Vaccine Data Published

Soligenix Submits NIAID Contract Proposal for Thermostable Ricin Vaccine

Innovative Platforms for Countermeasure Development – First Interim Deadline Extended

HHS Boosts Global Ability to Respond to Pandemics

New Blood Test for Anthrax to Speed Post-Exposure Treatment

BARDA Industry Day 2013

CBRN Medical Countermeasures BAA Deadline Extended

Animal Study Results for Intramuscular Anthrax Anti-Toxin

RFI – Radiation Medical Countermeasure Product Development Services

Biodefense News Headlines of the Week – July 21, 2013

SIGA Makes Third Delivery of Smallpox Drug for Biodefense Stockpile

BARDA Announces BAA for CBRN Medical Countermeasures

Biodefense News Headlines of the Week – July 7, 2013

Biodefense Headlines – 31 March 2025